Risk Factors for Residual Stenosis After Carotid Artery Stenting

Yunlu Tao1, Yang Hua1,2, Lingyun Jia1,2

  • 1Department of Vascular Ultrasonography, Xuanwu Hospital, Capital Medical University, Beijing, China.

Frontiers in Neurology
|February 15, 2021
PubMed

Insights

Stent type, plaque characteristics, and calcification influence residual stenosis after carotid artery stenting (CAS). Poor stent expansion increases residual stenosis risk, while good expansion is protective.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Residual stenosis after carotid artery stenting (CAS) is a significant risk factor for restenosis.
  • Understanding factors influencing residual stenosis is crucial for improving CAS outcomes.

Purpose of the Study:

  • To identify and analyze the independent risk factors for residual stenosis following CAS.
  • To evaluate the impact of stent type, plaque characteristics, and stent expansion on residual stenosis.

Main Methods:

  • Retrospective analysis of 570 patients undergoing CAS between January 2013 and January 2016.
  • Utilized carotid duplex ultrasonography and digital subtraction angiography to assess stenosis, plaque features, and residual stenosis (≥30%).
  • Logistic regression analysis was employed to determine risk factors for residual stenosis.

Main Results:

  • Overall residual stenosis incidence was 22.8%. Closed-loop stents (CLS) showed a higher incidence (29.5%) compared to open-loop stents (OLS) (20.2%).
  • Independent risk factors for residual stenosis included CLS use, irregular plaque morphology, and plaque calcification.
  • High stent radial expansion rate was a significant protective factor against residual stenosis.

Conclusions:

  • Plaque morphology (irregularity), calcification, and stent type (CLS vs. OLS) are key determinants of residual stenosis after CAS.
  • Optimal stent expansion is critical for minimizing residual stenosis and potentially reducing restenosis rates.
  • The study highlights the importance of pre-procedural plaque assessment and appropriate stent selection in CAS.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
144
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
110
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
660